🔴 Eupraxia Pharmaceuticals is trading 11.58% down in pre-market as global risk sentiment weakens

Eupraxia Pharmaceuticals is trading 11.58% down at $6.03, coinciding with weaker global risk sentiment.

• Shares closed at $6.82 on August 17, 2026.
• No new company-specific negative announcement was identified for August 18; the latest available company news highlighted durable RESOLVE-trial symptom improvements.
• The Nasdaq Composite is down 1.06%, amid heightened geopolitical and bond-market stress globally.